ENTRY       D06402                      Drug
NAME        Sunitinib malate (JAN/USAN);
            Sutent (TN)
PRODUCT     SUTENT (Pfizer Laboratories Div Pfizer)
            SUTENT (U.S. Pharmaceuticals)
  GENERIC   SUNITINIB MALATE (AvKARE)
            SUNITINIB MALATE (Dr.Reddys Laboratories)
            SUNITINIB MALATE (Mylan Pharmaceuticals)
            SUNITINIB MALATE (NorthStar RxLLC)
            SUNITINIB MALATE (Sun Pharmaceutical Industries)
            SUNITINIB MALATE (Teva Pharmaceuticals USA)
FORMULA     C22H27FN4O2. C4H6O5
EXACT_MASS  532.2333
MOL_WEIGHT  532.5612
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 4291
            ATC code: L01EX01
            Chemical structure group: DG00712
            Product (DG00712): D06402<JP/US>
EFFICACY    Antineoplastic, Angiogenesis inhibitor, Receptor tyrosine kinase inhibitor
  DISEASE   Gastrotintestinal stromal tumor [DS:H01591]
            Renal cell carcinoma [DS:H00021]
            Pancreatic neuroendocrine tumor [DS:H00045]
TARGET      CSF1R (FMS, CD115) [HSA:1436] [KO:K05090]
            FLT3 (CD135) [HSA:2322] [KO:K05092]
            PDGFR [HSA:5156 5159] [KO:K04363 K05089]
            RET [HSA:5979] [KO:K05126]
            VEGFR1 (FLT1) [HSA:2321] [KO:K05096]
            VEGFR2 (KDR) [HSA:3791] [KO:K05098]
            VEGFR3 (FLT4) [HSA:2324] [KO:K05097]
            KIT (CD117) [HSA:3815] [KO:K05091]
  PATHWAY   hsa04010(1436+2321+2322+2324+3791+3815+5156+5159)  MAPK signaling pathway
            hsa04014(1436+2321+2322+2324+3791+3815+5156+5159)  Ras signaling pathway
            hsa04151(1436+2321+2322+2324+3791+3815+5156+5159)  PI3K-Akt signaling pathway
            hsa04370(3791)  VEGF signaling pathway
            hsa05200(1436+2322+2324+3815+5156+5159+5979)  Pathways in cancer
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07045  Antineoplastics - protein kinase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EX Other protein kinase inhibitors
                 L01EX01 Sunitinib
                  D06402  Sunitinib malate (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Sunitinib
                D06402  Sunitinib malate (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D06402  Sunitinib malate (JAN/USAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG00712  Sunitinib
                 D06402  Sunitinib malate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00712  Sunitinib
                 D06402  Sunitinib malate
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               PDGFR family
                PDGFR
                 D06402  Sunitinib malate (JAN/USAN) &lt;JP/US&gt;
                KIT (CD117)
                 D06402  Sunitinib malate (JAN/USAN) &lt;JP/US&gt;
                FLT3 (CD135)
                 D06402  Sunitinib malate (JAN/USAN) &lt;JP/US&gt;
               VEGFR family
                VEGFR1 (FLT1)
                 D06402  Sunitinib malate (JAN/USAN) &lt;JP/US&gt;
                VEGFR2 (KDR)
                 D06402  Sunitinib malate (JAN/USAN) &lt;JP/US&gt;
                VEGFR3 (FLT4)
                 D06402  Sunitinib malate (JAN/USAN) &lt;JP/US&gt;
               RET family
                RET
                 D06402  Sunitinib malate (JAN/USAN) &lt;JP/US&gt;
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                CSF1R (FMS, CD115)
                 D06402  Sunitinib malate (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D06402
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D06402
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D06402
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D06402
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D06402
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG00712  Sunitinib
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00712  Sunitinib
DBLINKS     CAS: 341031-54-7
            PubChem: 47208059
            LigandBox: D06402
            NIKKAJI: J2.374.908D
ATOM        38
            1   C8x C    41.1025  -27.7475
            2   C8x C    39.9075  -28.4505
            3   C8y C    39.9075  -29.8564
            4   C8x C    41.1025  -30.5593
            5   C8y C    42.2975  -29.8564
            6   C8y C    42.2975  -28.4505
            7   C2y C    43.7033  -30.2781
            8   C5x C    44.4766  -29.1535
            9   N1x N    43.7033  -28.0288
            10  X   F    38.7126  -30.5593
            11  O5x O    45.8824  -29.1535
            12  C2b C    43.7033  -31.6839
            13  C8y C    44.8983  -32.3869
            14  C8y C    44.8983  -33.7928
            15  C8y C    46.2339  -34.2145
            16  C8y C    47.0071  -33.0899
            17  N4x N    46.2339  -31.9652
            18  C1a C    43.7033  -34.6362
            19  C1a C    48.4130  -33.0899
            20  C5a C    46.2339  -35.6203
            21  O5a O    45.0165  -36.3233
            22  N1b N    47.4514  -36.3233
            23  C1b C    48.6519  -35.6301
            24  C1b C    49.8443  -36.3184
            25  N1c N    51.0404  -35.6276
            26  C1b C    52.2349  -36.3171
            27  C1a C    53.4300  -35.6270
            28  C1b C    51.0404  -34.2148
            29  C1a C    52.2379  -33.5231
            30  C1c C    51.9013  -29.3983
            31  C1b C    53.1022  -30.0910
            32  C6a C    50.7070  -30.0910
            33  O1a O    51.9013  -28.0135
            34  C6a C    54.2965  -29.3983
            35  O6a O    49.5126  -29.3921
            36  O6a O    50.7132  -31.6079
            37  O6a O    55.4909  -30.0910
            38  O6a O    54.2902  -28.0135
BOND        39
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     8   9 1
            10    6   9 1
            11    3  10 1
            12    8  11 2
            13    7  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17   15  16 2
            18   16  17 1
            19   13  17 1
            20   14  18 1
            21   16  19 1
            22   15  20 1
            23   20  21 2
            24   20  22 1
            25   22  23 1
            26   23  24 1
            27   24  25 1
            28   25  26 1
            29   26  27 1
            30   25  28 1
            31   28  29 1
            32   30  31 1
            33   30  32 1
            34   30  33 1 #Up
            35   31  34 1
            36   32  35 1
            37   32  36 2
            38   34  37 1
            39   34  38 2
///
